You're using an outdated browser. This website will not display correctly and some features will not work.
Learn more about the browsers we support for a faster and safer online experience.

Important: This version of the e-Laws website will be upgraded to a new version in the coming weeks.
You can try the beta version of the new e-Laws at ontario.ca/laws-beta.

 

ontario regulation 338/03

made under the

ontario drug benefit act

Made: August 6, 2003
Filed: August 8, 2003
Printed in The Ontario Gazette: August 23, 2003

Amending O. Reg. 201/96

(General)

1. Clause 12 (1) (b) of Ontario Regulation 201/96 is revoked and the following substituted:

(b) a letter authorizing the Minister to gain access to all information with respect to the product in the possession of Health Canada, the Patented Medicine Prices Review Board established under section 91 of the Patent Act (Canada), the government of any province or territory in Canada or the Canadian Coordinating Office of Health Technology Assessment and authorizing the Minister to disclose any information with respect to the product in the possession of the Ministry to Health Canada, the Patented Medicine Prices Review Board, the government of a province or territory in Canada or the Canadian Coordinating Office of Health Technology Assessment;

2. This Regulation comes into force on September 4, 2003.